Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Completed × dexamethasone 21-phosphate × Clear all

Phase

Phase 2 16 Phase 1 13 Phase 3 7 Phase 1/2 5 Phase NA 3 Phase 2/3 2 Phase 4 1

Status

Unknown 1 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1 Neoplasms 1 Nausea 1

Interventions

Saline Solution 23 Metformin 23 Zoledronic Acid 22 Dexamethasone 20 Cytarabine 19 Cyclophosphamide 19 Bupivacaine 16 Sodium Chloride 15 Propofol 15 Vincristine 14 Morphine 14 Methotrexate 14 Letrozole 14 Fentanyl 13 Dexmedetomidine 13 Imiquimod 12 Doxorubicin 12 Docetaxel 12 Prednisolone 11 Mercaptopurine 11 Bevacizumab 11 Rituximab 10 Oxycodone 10 Everolimus 10 Cisplatin 10 Capecitabine 10 Acetaminophen 10 nilotinib 9 enzalutamide 9 Ropivacaine 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01636947 2018-09-25

KMEC

Merck Sharp & Dohme LLC

Phase 4 Completed

494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡